Blastomyces dermatitidis Gilchrist et Stokes, anamorph
Strain Designations
B-47
Alternate State
Ajellomyces dermatitidis McDonough et Lewis
Application
Biomedical Research and Development Material
Emerging infectious disease research
Biosafety Level
3
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format
frozen
Type Strain
no
Preceptrol®
no
Comments
Drug-induced alterations in ultrastructure
uptake of sulfur-containing compounds
GC content
Medium
ATCC® Medium 28: Emmons' modification of Sabouraud's agar
Growth Conditions
Temperature: 25.0°C
Name of Depositor
RG Garrison
Chain of Custody
ATCC <<--RG Garrison<<--D.J. Guidry <<--- J. Busey
References
Bawdon RE, et al. Deoxyribonucleic acid base composition of the yeastlike and mycelial phases of Histoplasma capsulatum and Blastomyces dermatitidis. J. Bacteriol. 111: 593-596, 1972. PubMed: 5053471
Garrison RG, et al. The uptake of low molecular weight sulfur-containing compounds by Histoplasma capsulatum and related dimorphic fungi. Mycopathol. Mycol. Appl. 40: 171-180, 1970. PubMed: 5455792
Lane JW, et al. Drug-induced alterations in the ultrastructural organization of Histoplasma capsulatum and Blastomyces dermatitidis. Mycopathol. Mycol. Appl. 48: 289-296, 1972. PubMed: 4119289
